Are you above the legal age to view this content in your province/state?

Home / Industry News / Study Shows CBD May Help to Fight Superbug Infections

Study Shows CBD May Help to Fight Superbug Infections

Study Shows CBD May Help to Fight Superbug Infections

U.S., June 27, 2019 (CBDORIGIN)- With the threat of antibiotic-resistant bacteria on the rise, scientists are researching what some would consider being an unconventional solution––Cannabidiol (CBD).

In a recent experiment conducted in a controlled environment, Botanix Pharmaceuticals, an Australian biotech research firm, demonstrated that CBD can eliminate gram-negative bacteria, a type of bacteria that has exhibited high resistance to antibiotics.

The lead researcher on the project, Dr. Mark Blaskovich of the University of Queensland, reported that in their studies, CBD had demonstrated safety for human use and believes that the anti-inflammatory properties within CBD could prove to be valuable in the future research of antibiotics.

Insights Revealed by this Research

In their studies, Dr. Blaskovich and his team found that CBD was effective in killing multiple gram-negative bacteria strains including Staphylococcus aureus, Streptococcus pneumoniae, and even MRSA, a staph bacteria highly recognized for its resilience to antibiotics.

In addition, the researchers reported that the bacteria were unable to develop a resistance to CBD, even after twenty-one days of exposure, which is where most antibiotics fall short.

According to the study, CBD had succeeded where almost every other antibiotic had failed because it was able to disrupt the protective layer of the bacteria known as the biofilm.

In a public statement issued earlier this month, Dr. Blaskovich remarked that he looks forward to “presenting this exciting data at the upcoming ASM Microbe conference in San Francisco.”

The Future of CBD Against Superbug Infections

While the findings revealed in this study are very promising, more research will be needed to determine the effectiveness of CBD against gram-negative bacteria outside of a laboratory environment.

If the findings revealed by Dr. Blaskovich’s research team can be repeated and refined outside of a laboratory environment, CBD could be a powerful solution against superbug infections in the future.

Matt Callahan, Executive Director and founder of Botanix said “The implications and potential applications of these remarkable results are immense.” Botanix has commented that they are looking to move to clinical trials later in 2019.


Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.

Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.

Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.

Investment Value Finders is intended for those 21+ years of age only!

Check Also

Stocks and Founds that are overexposed To Russia And Ukraine

Stock markets worldwide have been in red since Russia began its invasion of Ukraine last …